Clinical trial
ORI2 : ORI for hyperOxia Reduction in ICU
NCT02878460 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ORI2 : ORI for hyperOxia Reduction in ICU
- Lead sponsor
- University Hospital, Angers
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 27, 2017
- Completion date
- May 22, 2018
- Enrollment
- 150 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
intensive care units